Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Levodopa-Induced Dyskinesias in Parkinson's Disease
NCT00160576Phase 2Completed
- Sponsor
- UCB
- Start
- Jul 2003
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of levetiracetam in levodopa-induced dyskinesia (LID), sponsored by UCB. Started Jul 2003; status: completed.
02
Drugs
levetiracetam
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00160576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160576.